Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Total Liabilities and Share Holders Equity 2010-2025 | EVO

Evotec AG total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  
Evotec AG Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $2,070
2023 $2,438
2022 $2,378
2021 $2,644
2020 $1,671
2019 $1,323
2018 $912
2017 $754
2016 $389
2015 $320
2014 $299
2013 $302
2012 $290
2011 $304
2010 $255
2009 $204
Evotec AG Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $2,049
2024-12-31 $2,070
2024-09-30 $2,189
2024-06-30 $2,153
2024-03-31 $2,398
2023-09-30 $2,454
2023-06-30 $2,509
2022-12-31 $2,378
2022-09-30 $2,279
2022-06-30 $2,441
2022-03-31 $2,452
2021-12-31 $2,644
2021-09-30 $2,085
2021-06-30 $1,953
2021-03-31 $1,906
2020-12-31 $1,671
2020-09-30 $1,367
2020-06-30 $1,311
2020-03-31 $1,306
2019-12-31 $1,323
2019-09-30 $1,205
2019-06-30 $1,200
2019-03-31 $1,000
2018-12-31 $912
2018-09-30 $896
2018-06-30 $827
2018-03-31 $818
2017-12-31 $754
2017-09-30 $757
2017-06-30 $464
2017-03-31 $446
2016-12-31 $389
2016-09-30 $308
2016-06-30 $307
2016-03-31 $303
2015-12-31 $320
2015-09-30 $317
2015-06-30 $322
2015-03-31 $257
2014-12-31 $299
2014-09-30 $283
2014-06-30 $303
2014-03-31 $301
2013-12-31 $302
2013-09-30 $326
2013-06-30 $283
2013-03-31 $293
2012-12-31 $290
2012-09-30 $285
2012-06-30 $277
2012-03-31 $281
2011-12-31 $304
2011-09-30 $301
2011-06-30 $289
2011-03-31 $255
2010-12-31 $255
2010-09-30 $230
2010-06-30 $193
2010-03-31 $200
2009-12-31 $204
2009-09-30 $221
2009-06-30 $220
2009-03-31 $229
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.335B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.630B 30.25
Zoetis (ZTS) United States $69.973B 26.11
Takeda Pharmaceutical (TAK) Japan $46.997B 9.35
Daiichi Sankyo, - (DSNKY) Japan $42.922B 22.00
BeOne Medicines - (ONC) Cayman Islands $27.080B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.434B 0.00
Merck (MKKGY) Germany $16.421B 12.03
Summit Therapeutics (SMMT) United States $15.269B 0.00
Shionogi (SGIOY) Japan $14.428B 0.00
United Therapeutics (UTHR) United States $13.115B 11.60
Neurocrine Biosciences (NBIX) United States $12.524B 42.90
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.831B 0.00
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $7.053B 43.13
Madrigal Pharmaceuticals (MDGL) United States $6.344B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.030B 0.00
Ionis Pharmaceuticals (IONS) United States $5.954B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.031B 0.00
Hypermarcas (HYPMY) Brazil $3.075B 20.23
Crinetics Pharmaceuticals (CRNX) United States $2.824B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.742B 9.61
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
BioCryst Pharmaceuticals (BCRX) United States $2.113B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.016B 0.00
Indivior (INDV) United States $1.932B 8.19
Centessa Pharmaceuticals (CNTA) United Kingdom $1.660B 0.00
Endo (NDOI) United States $1.595B 0.00
ARS Pharmaceuticals (SPRY) United States $1.552B 0.00
Ocular Therapeutix (OCUL) United States $1.295B 0.00
Guardian Pharmacy Services (GRDN) United States $1.272B 0.00
Dyne Therapeutics (DYN) United States $1.173B 0.00
Harrow (HROW) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.050B 21.00
Enliven Therapeutics (ELVN) United States $1.045B 0.00
Verve Therapeutics (VERV) United States $0.986B 0.00
Akebia Therapeutics (AKBA) United States $0.967B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.888B 0.00
Ardelyx (ARDX) United States $0.852B 0.00
Elite Pharmaceuticals (ELTP) United States $0.793B 0.00
Cronos Group (CRON) Canada $0.717B 0.00
Xeris Biopharma Holdings (XERS) United States $0.705B 0.00
Xencor (XNCR) United States $0.608B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Altimmune (ALT) United States $0.570B 0.00
USANA Health Sciences (USNA) United States $0.569B 12.37
Relay Therapeutics (RLAY) United States $0.547B 0.00
Regulus Therapeutics (RGLS) United States $0.546B 0.00
Bioventus (BVS) United States $0.538B 13.65
Theravance Biopharma (TBPH) United States $0.532B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.494B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Oruka Therapeutics (ORKA) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.437B 9.13
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Savara (SVRA) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.86
Tonix Pharmaceuticals Holding (TNXP) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
Nanobiotix S.A (NBTX) France $0.211B 0.00
MediWound (MDWD) Israel $0.206B 0.00
OmniAb (OABI) United States $0.194B 0.00
ProKidney (PROK) United States $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.191B 0.00
Profound Medical (PROF) Canada $0.191B 0.00
Aldeyra Therapeutics (ALDX) United States $0.183B 0.00
Larimar Therapeutics (LRMR) United States $0.166B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Journey Medical (DERM) United States $0.152B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
VAXART, INC (VXRT) United States $0.132B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Lyell Immunopharma (LYEL) United States $0.129B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.115B 18.84
Ironwood Pharmaceuticals (IRWD) United States $0.114B 0.00
Nektar Therapeutics (NKTR) United States $0.106B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.087B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Dominari Holdings (DOMH) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.065B 48.33
Assertio Holdings (ASRT) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00